Newsroom
Latest News
News
Sera Appoints Robert G. Harrison As Chief Information Officer
March 31, 2021- Accomplished technology leader joins Sera to build and deploy its information strategy.
News
American Medical Association (AMA) Grants Sera A Cpt® Pla Code For PreTRM®, The Only Broadly Validated Blood Test To Assess Risk Of Preterm Birth
February 3, 2021- Receipt of dedicated CPT® code marks important commercialization milestone to pursue reimbursement for the PreTRM® Test.
News
Sera Partners With Anthem and HealthCore to Improve Outcomes for Preterm Babies
January 05, 2021- Patient enrollment began in November for this rigorous prospective, randomized, controlled PRIME intervention trial to demonstrate the value of implementing the PreTRM® prevention strategy to improve neonatal outcomes and lower cost of care.
News
Sera to Present at Baird’s 2020 Global Health Care Conference
September 9, 2020- Sera will be presenting at the upcoming Baird 2020 Global Health Care Conference. A virtual conference, Sera’s presentation will take place on Thursday, September 10 at 10:50 a.m. ET.
News
Sera Appoints Thomas J. Garite, M.D. as Vice President of Clinical Sciences
June 24, 2020 – Sera announced the appointment Thomas J. Garite, M.D. as Vice President of Clinical Sciences. – Dr. Garite will support clinical development and operations as Sera transitions from clinical to commercial-stage company.
News
Publication Demonstrates Ability of Sera’ PreTRM® Biomarker Test as a Predictor of Adverse Pregnancy Outcomes
May 20, 2020 – Sera, Inc., The Pregnancy Company® announced the publication of positive data in a large, independent, contemporary prospective U.S. clinical cohort study, TREETOP (NCT02787213), in the American Journal of Obstetrics & Gynecology Maternal Fetal Medicine.
News
Sera Appoints Jay M. Moyes as Chief Financial Officer
April 2, 2020 – Sera announced the appointment of Jay M. Moyes as Chief Financial Officer.
News
Sera to Present at the 40th Annual Cowen Health Care Conference
Feb 24, 2020 — Sera will be presenting at the upcoming Cowen 2020 Health Care Conference at the Boston Marriott Copley Place in Boston on Tuesday, March 3rd, at 11:30 a.m. ET.
News
Data Confirming Performance of Sera Prognostic’s PreTRM® Test Predictor in an Independent Large Cohort and Testing Enhancements to be Presented at the Society for Maternal-Fetal Medicine’s 40th Annual Pregnancy Meeting
Jan 28, 2020 — Sera announced two podium presentations describing the performance of the company’s technologies for predicting the individual risk of prematurity for women when prospectively tested in mid pregnancy.
News
Sera Announces Completion Of Important Prevent PTB Clinical Intervention Study Using The Pretrm® Test
Jan 9, 2020 – Sera announced the completion of the Prevent PTB clinical study conducted by Intermountain Healthcare. This study is the first of its kind to measure the impact on maternal and neonatal health and healthcare costs when standard medical interventions are used to proactively treat mothers screened at high risk for prematurity by the PreTRM® Test.